Expression of Serotonin2C Receptors in Pyramidal and GABAergic Neurons of Rat Prefrontal Cortex. A Comparison with Striatum by Santana, Noemí & Artigas, Francesc
For Peer Review
 
 1 
 
 (CerCor-2015-00573R2) 
 
 
 
 
 
Expression of Serotonin2C Receptors in Pyramidal and GABAergic Neurons 
of Rat Prefrontal Cortex. A Comparison with Striatum 
 
 
Noemí Santana1,2 and Francesc Artigas1,2,3 
 
1
Institut d'Investigacions Biomèdiques de Barcelona (IIBB), Consejo Superior de Investigaciones 
Científicas (CSIC), Spain 
2
Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain 
3
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Spain 
 
 
 
 
 
Running title: 5-HT2C receptors in prefrontal cortex  
 
 
 
 
 
 
 
Corresponding author: Francesc Artigas, PhD; Dept. of Neurochemistry and 
Neuropharmacology, IIBB-CSIC (IDIBAPS), Rosselló, 161, 6th floor, 08036 Barcelona, Spain. 
Phone: +3493-363 8315; Fax: +3493-363 8301; e-mail: fapnqi@iibb.csic.es 
Page 1 of 38 Cerebral Cortex
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
 2 
Abstract 
 
The prefrontal cortex (PFC) is enriched in several serotonin receptors, including 5-HT1A-R, 5-
HT2A-R and 5-HT3-R. These receptors modulate PFC activity due to their expression in large 
neuronal populations (5-HT1A-R, 5-HT2A-R) or in selected GABAergic populations (5-HT3-R). They 
are also relevant for antidepressant and antipsychotic drug action. Less is known about the 
localization of 5-HT2C-R, for which atypical antipsychotics show high affinity. Here we report on 
the cellular distribution of 5-HT2C-R in rat PFC and striatum, using double in situ hybridization 
histochemistry. In PFC, 5-HT2C-R are expressed in pyramidal (VGLUT1-positive) and GABAergic 
(GAD-positive) neurons, including parvalbumin-positive neurons. There is a marked dorso-
ventral gradient in the proportion of VGLUT1-positive cells expressing 5-HT2C-R, (9% in 
cingulate cortex, 61% in tenia tecta and 66% in piriform cortex), less marked for GABAergic 
neurons (13-27%). There is also a laminar gradient, with more cells expressing 5-HT2C-R in deep 
(V-VI) than in intermediate (II-III) layers. In common with 5-HT3-R, layer I GABAergic cells 
express 5-HT2C-R. The proportion of 5-HT2C-R-expressing striatal neurons was 23% (dorsolateral 
caudate-putamen), 37% (ventromedial caudate-putamen), 53% (nucleus accumbens-core) and 
49% (nucleus accumbens-shell). These results help to better understand the serotonergic 
modulation of PFC-based networks, including basal ganglia circuits, and atypical antipsychotic 
drug action. 
 
 
 
 
Key words: 5-HT2C receptors, atypical antipsychotic drugs; GABA interneurons, prefrontal 
cortex, pyramidal neurons 
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Introduction 
 
The prefrontal cortex (PFC) is deeply involved in higher brain functions, altered in psychiatric 
conditions. The PFC exerts a top-down control of most cortical and subcortical areas through 
descending pathways (Groenewegen and Uylings 2000; Fuster 2001; Miller and Cohen 2001). 
In turn, the PFC is densely innervated by serotonergic axon terminals and is enriched in several 
serotonin receptors, mainly 5-HT1A-R and 5-HT2A-R (Pazos and Palacios  et al. 1985; Pompeiano  
et al. 1992, 1994; Jakab and Goldman-Rakic 2000). These receptors are present in a relatively 
high proportion of pyramidal neurons and GABAergic interneurons (Santana  et al. 2004; De 
Almeida and Mengod 2007, 2008) and play a crucial role in modulating pyramidal neuron 
activity and cortical networks (Araneda and Andrade 1991; Zhou and Hablitz 1999; Férézou  et 
al. 2002; Puig  et al. 2003, 2005; Celada  et al. 2013a). Second generation (atypical) 
antipsychotic drugs show high affinity for 5-HT2A-R (Bymaster  et al. 1996; Arnt and Skarsfeldt 
1998; Meltzer 1999) and behave as direct or indirect agonists of 5-HT1A-R (Díaz-Mataix  et al. 
2005; Newman-Tancredi 2010; Celada  et al. 2013b). On the other hand, 5-HT3-R are present in 
a subpopulation of GABAergic interneurons not expressing parvalbumin or somatostatin and 
display strong actions on neuronal activity due to their ion channel structure (Morales  et al. 
1996; Puig  et al. 2004; Lee  et al. 2010), 5-HT3-R blockade may improve cognitive function (du 
Jardin  et al. 2014; Wallace  et al. 2014) and is involved in the therapeutic properties of the 
new antidepressant drug vortioxetine (Sanchez  et al. 2015).  
 Much less is known on the cellular expression and laminar distribution of other 5-HT-R, 
such as 5-HT2C-R, which shows a moderate expression in PFC (Pompeiano  et al. 1994). The 5-
HT2C-R is a G-protein coupled receptor that activates the phospholipase C signalling pathway. It 
is the only 5-HT-R that undergoes A-to-I type RNA editing, which dynamically regulates its 
constitutive activity (Berg  et al. 2008; Werry  et al. 2008; Aloyo  et al. 2009; O’Neil and Emeson 
2012).  
Classically, the 5-HT2C-R has been related to obesity, since 5-HT2C-R knockout mice are 
obese (Tecott  et al. 1995) and 5-HT2C-R agonists decrease appetite in obese patients (Sargent  
et al. 1997). Consequently, the weight gain associated to atypical antipsychotic drugs has been 
attributed to blockade of 5-HT2C-R, for which they show high affinity (Bymaster  et al. 1996; 
Arnt and Skarsfeldt 1998), acting as inverse agonists (Meltzer 2012). However, other receptors 
have also been implicated, such as the H1-R (Kim  et al. 2007). 
In addition to its involvement in weight control (likely through blockade of 
hypothalamic 5-HT2C-R (Hsu  et al. 2010)), the presence of 5-HT2C-R in PFC and anatomically 
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 4 
related brain areas suggests that it may participate in cognitive and affective functions (Heisler  
et al. 2007; Boulougouris and Robbins 2010; Pennanen  et al. 2013). In addition, midbrain 5-
HT2C-R tonically inhibit the activity of the ascending dopaminergic pathways (Gobert  et al. 
2000; Di Matteo  et al. 2002; De Deurwaerdère  et al. 2004; Di Giovanni  et al. 2006). They are 
also present in raphe GABA neurons, where they may exert a negative feed-back control of 
serotonergic activity (Serrats  et al. 2009). Hence, 5-HT2C-R blockade may have a pro-cognitive 
effect by locally modulating PFC networks as well as by enhancing cortical DA function. 
Moreover, 5-HT2C-R blockade may have a therapeutic action in affective disorders since it 
augments the citalopram-evoked serotonin (5-HT) output in the hippocampus and PFC 
(Cremers  et al. 2004, 2007). Likewise, the antidepressant drug agomelatine is a mixed 
melatonergic MT1/MT2-R agonist and 5-HT2C-R antagonist (Racagni  et al. 2011; Srinivasan  et 
al. 2012). The latter activity is involved in the agomelatine-induced increase of dopamine and 
noradrenaline in PFC –but not in dorsal or ventral striatum- (Millan  et al. 2003). Furthermore, 
5-HT2C-R agonists have been suggested as potential treatments for drug dependence (Devroye  
et al. 2013). 
The brain networks involved in the above cognitive and affective actions are poorly 
know, partly due to a limited knowledge of the cellular and laminar expression of 5-HT2C-R in 
PFC. In the present study, we examined the expression of 5-HT2C-R mRNA in pyramidal neurons 
(VGLUT1-positive) and GABAergic interneurons (GAD-positive) of rat PFC, as well as its laminar 
distribution using double in situ hybridization histochemistry. Likewise, given the major role 
played by parvalbumin (PV)-positive GABA interneurons in cognitive control and in 
schizophrenia symptoms (Gonzalez-Burgos and Lewis 2012; Lewis  et al. 2012; Sohal 2012) we 
also examined the expression of 5-HT2C-R mRNA in this particular subtype of GABA 
interneurons. In order to compare the expression of 5-HT2C-R mRNA in PFC with that in an area 
with a high receptor density, we examined the cellular expression of 5-HT2C-R mRNA in 
GABAergic neurons of the dorsal (caudate-putamen, CPu) and ventral (nucleus accumbens, 
Acb) striatum.  
 
 
Experimental procedures 
 
Tissue preparation 
Male albino Wistar rats weighing 250–300 g were used (Iffa Credo, Lyon, France). Animals 
were kept in a controlled environment (12 h light-dark cycle and 22 ± 2°C room temperature) 
with food and water provided ad libitum. Animal care followed the European Union 
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 5 
regulations (directive 2010/63 of 22 September 2010) and was approved by the Institutional 
Animal Care and Use Committee. Rats were killed by decapitation and the brains rapidly 
removed, frozen on dry ice and stored at –20°C. Tissue sections, 14-µm thick, were cut using a 
microtome-cryostat (HM500 OM; Microm, Walldorf, Germany), thaw-mounted onto APTS (3-
aminopropyltriethoxysilane; Sigma, St Louis, MO) coated slides and kept at –20°C until use. 
 
Hybridization probes 
The oligodeoxyribonucleotide probes used were as follows. For 5-HT2C receptor mRNA two 
oligonucleotides were simultaneously used, complementary to bases 1667-1714 and 1196-
1236 (GenBank accession number NM_012765). The probes were synthesized on a 380 
Applied Biosystem DNA synthesizer (Foster City Biosystem, Foster City, CA, USA) and purified 
on a 20% polyacrylamide/8 M urea preparative sequencing gel. Glutamatergic cells were 
identified by the presence of the vesicular glutamate transporter 1 (VGLUT1) mRNA, with two 
oligonucleotides complementary to bases 127-172 and 1756-1800 (GenBank accession number 
U07609). GABAergic cells were identified by the presence of the GABA synthesizing enzyme, 
glutamic acid decarboxylase (GAD). One oligonucleotide for the GAD67 isoform was used, 
complementary to bases 1600-1653 (GeneBank accession number NM_017007). PV-positive 
cells were detected by one oligonucleotide probe complementary to bases 329-373 (GenBank 
accession number NM_002854). They were synthesized and HPLC purified by Isogen 
Bioscience BV (De Meern, The Netherlands).  
Each 5-HT2C receptor oligonucleotide was individually labeled (2 pmol) at its 3’-end 
with [33P]-dATP (>2500 Ci/mmol; PerkinElmer NEN Radiochemicals, Boston, MA, USA) using 
terminal deoxynucleotidyltransferase (TdT, Calbiochem, Darmstadt, Germany). VGLUT1, GAD 
and PV oligonucleotides (100 pmol) were non-radioactively labeled with recombinant TdT 
(Roche Diagnostics GmbH, Penzberg, Germany) and digoxigenin (DIG)-11-dUTP (Boehringer 
Mannheim, Mannheim, Germany) according to a previously described procedure (Schmitz , 
1991). Labeled probes were puriﬁed using ProbeQuant G-50 Micro Columns (GE Healthcare, 
Buckinghamshire, UK). 
 
In situ hybridization histochemistry procedure 
The protocols for single- and double-label in situ hybridization histochemistry were based on 
previously described procedures (Tomiyama  et al. 1997; Landry  et al. 2000) and have been 
reported in detail (Serrats  et al. 2003). Frozen tissue sections were first brought to room 
temperature, fixed for 20 min at 4ºC in 4% paraformaldehyde in phosphate-buffered saline (1x 
PBS: 8 mM Na2HPO4, 1.4 mM KH2PO4, 136 mM NaCl, 2.6 mM KCl), washed for 5 min in 3x PBS 
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 6 
at room temperature, twice for 5 min each in 1x PBS, and incubated for 2 min at 21ºC in a 
solution of predigested pronase (Calbiochem, San Diego, CA, USA) at a final concentration of 
24 U/ml in 50 mM Tris-HCl pH 7.5, 5 mM EDTA. The enzymatic activity was stopped by 
immersion for 30 sec in 2 mg/ml glycine in 1x PBS. Tissues were finally rinsed in 1x PBS and 
dehydrated through a graded series of ethanol. For hybridization, the radioactively-labeled and 
the non-radioactively labeled probes were diluted in a solution containing 50% formamide, 4x 
SSC (1x SSC: 150 mM NaCl, 15 mM sodium citrate), 1x Denhardt’s solution (0.02% Ficoll, 0.02% 
polyvinylpyrrolidone, 0.02% bovine serum albumin), 10% dextran sulfate, 1% sarkosyl, 20 mM 
phosphate buffer pH 7.0, 250 µg/ml yeast tRNA and 500 µg/ml salmon sperm DNA. The final 
concentrations of radioactive and Dig-labeled probes in the hybridization buffer were in the 
same range (approximately 1.5 nM). Tissue sections were covered with hybridization solution 
containing the labeled probe/s, overlaid with Nescofilm coverslips (Bando Chemical Ind, Kobe, 
Japan) and incubated overnight at 42ºC in humid boxes. Sections were then washed four times 
(45 min each) in 0.6 M NaCl, 10 mM Tris–HCl pH 7.5 at 60 ºC, and once in the same buffer at 
room temperature for 30 min. 
 
Development of radioactive and non-radioactive hybridization signal 
Hybridized sections were treated as described by Landry (2000). Briefly, after washing, the 
slides were immersed for 30 min in a buffer containing 0.1 M Tris-HCl pH 7.5, 1 M NaCl, 2 mM 
MgCl2 and 0.5% bovine serum albumin (Sigma, Steinheim, Germany) and incubated overnight 
at 4ºC in the same solution with alkaline-phosphate-conjugated anti-digoxigenin-F(ab) 
fragments (1:5000; Roche Diagnostics GmbH, Mannheim, Germany). Afterwards, they were 
washed three times (10 min each) in the same buffer (without antibody), and twice in an 
alkaline buffer containing 0.1 M Tris-HCl pH 9.5, 0.1 M NaCl, and 5 mM MgCl2. Alkaline 
phosphatase activity was developed by incubating the sections with 3.3 mg nitroblue 
tetrazolium and 1.65 mg bromochloroindolyl phosphate (Roche Diagnostics GmbH, Mannheim, 
Germany) diluted in 10 ml of alkaline buffer. The enzymatic reaction was blocked by extensive 
rinsing in the alkaline buffer containing 1 mM EDTA. The sections were then briefly dipped in 
70% and 100% ethanol, air-dried and dipped into Ilford K5 nuclear emulsion (Ilford, Mobberly, 
Chesire, UK) diluted 1:1 with distilled water. They were exposed in the dark at 4°C for 6 weeks, 
and finally developed in Kodak D19 (Kodak, Rochester, NY, USA) for 5 min, and fixed in Ilford 
Hypam fixer (Ilford).For ﬁlm autoradiography, some hybridized sections were exposed to 
Biomax-MR (Kodak) ﬁlms for 2–4 weeks at -70 ºC with intensifying screens.  
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 7 
Specificity of the probes 
The specificity of the hybridization signals has been previously established and published 
(Pompeiano  et al. 1992; Serrats  et al. 2003). These controls included the following 
procedures. 1) The thermal stability of the hybrids was examined for every probe by washing 
at increasing temperatures: a sharp decrease in the hybridization signal was observed at a 
temperature consistent with the Tm of the hybrids. 2) For a given oligonucleotide probe, the 
hybridization signal was completely blocked by competition of the labeled probe in the 
presence of 50-fold excess of the same unlabeled oligonucleotide. 3) Since we synthesized 
more than one probe for each mRNA analyzed, the hybridization signal obtained with each 
oligonucleotide for the same mRNA was identical at both regional and cellular levels when 
used independently. 4) To assure the specificity of the non-radioactive hybridization signal, we 
compared the results obtained with the same probe radioactively labeled. 
 
Analysis of the results 
Tissue sections were examined and cells quantiﬁed with an Olympus BX51 Stereo Microscope 
(Olympus, Tokyo, Japan) equipped with an Olympus Microscope Digital Camera DP71 and 
Visiopharm Integrator System (VIS) (Visiopharm Software, Hørsholm, Denmark). Co-expression 
of VGLUT1, GAD or PV mRNAs (all Dig-labeled) with 5-HT2C-R mRNA (radioactively labeled) was 
estimated by counting the number of Dig-labeled cellular profiles which also expressed 5-HT2C-
R mRNA, using a systematic random sampling tool. The number of Dig-labeled cells was 
considered as 100% (either VGLUT1, GAD or PV). Only cellular profiles showing three-fold 
density of silver grains higher than background were considered to be double-labeled. For 
cortical counting estimation, regions of interest (ROIs) were drawn in each layer and PFC 
subdivision with the aid of VIS software using Swanson brain map´s layers as reference 
(Swanson 2004). Moreover, cytoarchitectonic criteria of VGLUT1-positive sections, including 
differential shape and size of cells in cortical layers II-VI, were used as an internal control. For 
delineation of ROIs in striatum, the Paxinos and Watson (2005) brain map was used as 
reference. Dorsolateral and ventromedial CPu subdivisions were chosen using connectivity 
criteria (Voorn  et al. 2004). Nucleus accumbens (Acb) core boundaries were delineated using 
the inferior tip of the lateral ventricle and the anterior commissure as reference. Acb shell 
boundaries were estimated using ventral pallidum as ventral reference and lateral septum as 
medial reference. Data are means ± SEM of three rats (triplicate sections per rat). The figures 
were prepared for publication using Adobe Photoshop software (Adobe Software, Mountain 
View, CA, USA). Analysis of variance (ANOVA) and post-hoc Tukey's (for one-way ANOVA) or 
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 8 
Bonferroni (for two-way ANOVA) tests were performed using GraphPad Prism software 
(GraphPad Software, San Diego, CA, USA). P < 0.05 was considered statistically significant. 
 
 
Results  
 
Figure 1 shows the expression pattern of 5-HT2C-R mRNA in several subcortical structures along 
the rostro-caudal axis of rat brain. The most prominent expression of this receptor was found 
in choroid plexuses of 3rd and lateral ventricles (B1) and CA1/ventral subiculum (VS) 
subdivisions of the ventral hippocampus (C1). A moderate-high expression was found in 
striatal structures such as the nucleus accumbens (Acb), the caudate-putamen (CPu) and the 
ventral tegmental area (VTA). Likewise, some thalamic nuclei, as well as the retrosplenial 
cortex (Rs), exhibited a high expression of this receptor (B1, C1).  
 
Expression of 5-HT2C-R mRNA in PFC subfields  
In the PFC, the expression of the 5-HT2c-R transcript showed a marked dorso-ventral gradient, 
with a moderate expression in dorsal compared with ventral fields. In dorsal fields, the most 
prominent expression was seen in deep layers (V-VI) of the three medial prefrontal cortex 
(mPFC) subdivisions, infralimbic (IL), prelimbic (PrL) and dorsal anterior cingulate (Cg), which 
exhibited the lower expression. Other cortical areas, such as the primary and secondary motor 
areas (M1/M2), the agranular insular cortex (AI) and the ventral/lateral orbital cortex (VO/LO) 
also expressed the 5-HT2c-R transcript. PFC areas ventral to the rhinal fissure (from now on, 
referred to as "ventral PFC"), such as tenia tecta (TT), piriform cortex (Pir) and anterior 
olfactory nucleus (AON) were more enriched in 5-HT2C-R mRNA than more dorsal areas of PFC 
(Figs. 2 and 3).  
We examined the cellular distribution of 5-HT2c-R mRNA in pyramidal (VGLUT1-
positive) and GABAergic (GAD-positive) neurons (Fig. 4). Both neuronal types expressed 5-HT2c-
R in all subdivisions of PFC examined, yet in a greater proportion by pyramidal cells in ventral 
PFC subdivisions, such as TT and Pir (see below). A moderate proportion of PV-positive cells, a 
subgroup of GABAergic interneurons, expressed 5-HT2c-R.  
An abundant proportion of cells in ventral and ventro-lateral areas of PFC expressed 
5-HT2C-R mRNA (Fig. 5). Panels A1-A5 show the presence of 5-HT2c-R mRNA in pyramidal 
neurons of these areas. A great number of pyramidal cells expressing 5-HT2c-R were observed 
in piriform cortex and AON, whereas a more moderate number were found in AI. A large 
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 9 
proportion of GABAergic cells of Acb at this AP level (panel B1) showed the presence of this 
receptor. Glutamatergic, GABAergic or PV-positive cells of orbital cortex expressed 5-HT2c-R 
mRNA in a low proportion.  
Figure 6 shows the quantitative distribution of 5-HT2c-R mRNA in glutamatergic, 
GABAergic and PV-positive neurons of mPFC subdivisions (IL, PrL and Cg), VO/LO, AI, TT and 
Pir. Overall, 5-HT2c-R expression was moderate in dorsal aspects of the mPFC and AI, with a 
similar percentage of excitatory and inhibitory neurons expressing 5-HT2c-R. However, ventral 
PFC areas such as TT and Pir exhibited a much greater proportion of pyramidal neurons 
expressing 5-HT2c-R (~60%), which was three times greater than that of GABAergic 
interneurons expressing 5-HT2c-R in the same areas.  
One-way ANOVA showed a significant effect of the region on the proportion of 
VGLUT1-positive neurons expressing 5-HT2c-R (region factor: F6,14=490.7, p<0.0001). Nine to 
sixteen percent of VGLUT1-positive cells expressed 5-HT2c-R, with a dorso-ventral positive 
gradient, being IL the area where maximal expression was found. Almost 20% of AI 
glutamatergic neurons expressed the 5-HT2c-R. The percentage of GABAergic cells expressing 
5-HT2c-R was slightly higher than that of glutamatergic cells, particularly in Cg (13.5 vs. 9.5%, 
respectively) and was similar in PrL and IL, exhibiting also a DV positive gradient (region factor: 
F7,16=14.07, p<0.0001, one-way ANOVA). Although there were some differences in the 
percentage of GABAergic neurons expressing 5-HT2c-R in the different mPFC areas, these did 
not reach statistical significance in most instances, except in TT and VO/LO (Fig. 6). 
Interestingly, unlike other G protein-coupled 5-HT-R (see discussion), a 10% of 
GABAergic cells in layer I expressed 5-HT2c-R. A small proportion of PV-positive neurons 
expressed 5-HT2c-R mRNA in all areas examined (see mean and deviation values in 
Supplementary Table 1). 
Figure 7 shows the layer distribution of 5-HT2c-R mRNA in mPFC. About 15% of 
pyramidal cells in deep layers of mPFC expressed the 5-HT2c-R transcript. As observed for all 
sections examined at this AP coordinate, in the mPFC layers V-VI there was also a positive 
dorso-ventral gradient in the percentage of cells expressing 5-HT2c-R in deep layers, with a 
higher expression in IL > PrL > Cg (Fig. 7A). The percentage of pyramidal cells expressing 5-HT2c-
R in layers II-III was low (ca. 5% on average) and also showed a positive dorso-ventral gradient. 
The expression of 5-HT2c-R was significantly lower in layers II-III compared with layers V-VI in all 
three mPFC subdivisions (layer factor: F2,12 = 12.05, p<0.005; region factor: F1,12 = 72.56, 
p<0.0001, two-way ANOVA).  
The percentage of GABAergic cells expressing 5-HT2c-R mRNA was ~10% in layers V-VI 
of the IL, PrL and Cg subdivisions and was very similar in all of them (Fig. 7B). Interestingly, the 
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 10 
percentage of GABAergic cells expressing 5-HT2c-R mRNA in layers II-III exhibited a positive 
dorso-ventral gradient, similar to that exhibited by pyramidal (VGLUT1+) neurons in the same 
layers, although this difference did not reach statistical significance (layer factor: F2,12 = 3.393, 
p = 0.0679;  region factor: F1,12 = 0.8417, p=0.3770, two-way ANOVA).  
 The percentage of PV-positive cells expressing the 5-HT2c-R mRNA was lower than that 
of all GABAergic cells in all layers and subdivisions, suggesting that the receptor is expressed in 
different subtypes of GABAergic interneurons. The difference was maximal in layers II-III of the 
IL subdivision, where less than 5% of PV-positive cells express 5-HT2c-R (compared to the ~15% 
of GAD-positive cells in the same location (Fig. 7C).  
 
Comparison with rostral PFC and striatum 
In order to compare 5-HT2C-R PFC expression with more rostral and posterior areas also rich in 
5-HT2C-R mRNA, we examined its distribution in 1) a more rostral coordinate within the PFC 
(bregma +5.1 mm; Fig. 8), and 2) a more caudal coordinate (bregma +2.2 mm), a section 
including the CPu and the shell and core subdivisions of Acb (Fig. 9). In rostral PFC, the 
expression of the 5-HT2C-R transcript was more prominent in deep vs superficial layers of all 
subdivisions: primary and secondary motor areas (M1/M2), PrL, medial orbital cortex (MO), 
VO/LO and dorsolateral orbital cortex (DLO) (Fig. 8A). The proportion of pyramidal (VGLUT1-
positive) and GABAergic (GAD-positive) neurons expressing 5-HT2C-R mRNA in these areas is 
shown in Figure 8B. Both neuronal types expressed 5-HT2C-R in a similar proportion (~15% on 
average) in all subdivisions examined. PrL was the area with greatest expression of 5-HT2C-R 
mRNA, although the difference did not reach statistical significance in either neuronal type 
[region factor: F3,8=0.8501, p=0.5045 (VGLUT1-positive cells), F3,8=1.518, p=0.2827 (GAD-
positive cells), one-way ANOVA] (Fig. 8B1).  
Considering layer subdivision, 5-HT2C-R mRNA expression was significantly higher in 
layers V-VI than in layers II-III of ventrolateral aspects of orbital cortex at this AP coordinate. 
About 30-40% of VGLUT1-positive cells in layers V-VI contain 5-HT2C-R mRNA, opposite to a 
much lower expression (~5%) in superficial layers (II-III) (layer factor: F1,8 = 88.31, p<0.0001; 
region factor: F1,8 = 3.814, p=0.0866, two-way ANOVA) (Figure 8B2). On the other hand, the 
percentage of GABAergic cells expressing 5-HT2C-R was significantly higher in deep than in 
superficial layers of DLO, but not in VO/LO, were all layers expressed the same proportion of 
this receptor (nearly 10% of GAD-positive cells) (layer factor: F1,8 = 0.6509, p=0.4431; region 
factor: F1,8 = 3.375, p=0.1035; interaction: F1,8 = 6.576, p<0.05, two-way ANOVA) (Figure 8B3). 
Figure 8C (panels C1-C4) show examples of 5-HT2C-R expression in layers V-VI of VO/LO and 
DLO at AP +5.1 mm from bregma. 
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 11 
5-HT2C-R mRNA is highly expressed in all striatum subdivisions (bregma +2.2 mm); Fig. 
9). Acb core showed the highest proportion of cells expressing 5-HT2C-R at this AP coordinate, 
where almost 60% of GABAergic cells express 5-HT2C-R mRNA. In contrast, the receptor was 
less expressed in dlCPu cells (ca. 20%). One-way ANOVA showed a significant effect of the 
region on the proportion of GAD-positive neurons expressing 5-HT2C-R (region factor: F3,8=18.9, 
p<0.001) (Fig. 9C).  
 
 
Discussion  
 
The present report complements and extends previous studies of our group on the role of 
monoaminergic innervation in the control of PFC activity, and in particular, on the expression 
of monoaminergic receptors by pyramidal neurons and GABAergic interneurons. Figure 11 
shows the regional distribution in the PFC of the mRNAs encoding four serotonergic receptors 
(5-HT1A-R, 5-HT2A-R, 5-HT2C-R and 5-HT3-R), dopamine D1-R and D2-R and α1A-, α1B- and α1C-
adrenoceptors, as well as their proportions in pyramidal and GABAergic neurons in the 
different mPFC subdivisions, as  observed in previous and present studies (Amargós-Bosch  et 
al. 2004; Puig  et al. 2004; Santana  et al. 2004, 2009, 2013). With the exception of 5-HT3-R, 
selectively expressed in GABAergic interneurons located mainly in layers I-III, the rest of 
monoaminergic receptors are present in both neuronal types in varying proportions, and in 
middle (II-III) and deep (V-VI) layers of the Cg, Prl and IL subdivisions. Some of them are highly 
co-localized in mPFC (5-HT1A-R and 5-HT2A-R, Amargós-Bosch et al., 2004; 5-HT2A-R  and α1-
adrenoceptors, Santana et al. 2013) while other show little overlap (D1-R and D2-R, Santana et 
al. 2009) in mPFC. Overall, this suggestss a complex monoaminergic control of PFC activity, 
with some convergent actions on the same neuronal populations as well as selective actions 
on separate populations.  
Early in situ hybridization and autoradiographic studies identified the presence of 5-
HT2C-R in several brain areas, including the neocortex (prefrontal, piriform, retrosplenial and 
entorhinal cortices) and subcortical structures such as basal ganglia, amygdala, hippocampus 
and monoaminergic nuclei (Pazos and Palacios 1985; Molineaux  et al. 1989; Mengod  et al. 
1990; Pompeiano  et al. 1994; Eberle-Wang  et al. 1997; López-Giménez  et al. 2001). 
Immunohistochemical analyses found a similar regional distribution (Abramowski  et al. 1995; 
Clemett  et al. 2000). At the cellular level, the 5-HT2C-R has been identified in GABAergic and 
dopaminergic cells of the ventral tegmental area (Bubar and Cunningham 2007) and in 
GABAergic cells of the dorsal raphe and PFC (Serrats  et al. 2005; Boothman  et al. 2006; Liu  et 
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 12 
al. 2007). Likewise, 5-HT2C-R have been identified in glutamatergic cells using single cell RT-PCR 
(Vysokanov  et al. 1998; Feng  et al. 2001; Carr  et al. 2002). 
The regional distribution of 5-HT2c-R mRNA in PFC reported herein agrees well with 
early work using in situ hybridization and autoradiographic studies (Pazos and Palacios 1985; 
Mengod  et al. 1990; Pompeiano  et al. 1994). We found that the 5-HT2c-R mRNA is unevenly 
distributed in rat PFC, with a marked dorso-ventral gradient, which may follow the distribution 
of 5-HT itself, and suggests the involvement of 5-HT2C-R in emotional processing. In this regard, 
5-HT depletion impairs reward-associated reversal learning but not the more abstract extra-
dimensional shift learning (Clarke et al., 2005). In the mPFC 5-HT2c-R mRNA is present in 
pyramidal neurons (VGLUT1-positive) and GABAergic interneurons (GAD-positive), with a 
greater abundance in deep layers of the mPFC (V-VI, mainly in the boundary between both 
layers) than in intermediate layers (II-III) showing also a positive dorso-ventral gradient (e.g., 
IL>PrL>Cg). Interestingly, the higher proportion of neurons expressing 5-HT2c-R mRNA in layers 
V-VI was also found at a more rostral PFC coordinate (bregma +5.1 mm), indicating a 
preferential distribution of the receptor in deep layers along the rostro-caudal axis, 
The receptor is also expressed in PV-positive neurons, although in a lower proportion 
than in the total of GABAergic neurons. Ventral prefrontal areas, such as olfactory and striatal 
structures (AON, Pir and rostral Acb) express abundantly 5-HT2C-R mRNA. To our knowledge, 
this is the first quantitative study of the expression of this receptor at cellular level in 
mammalian cortex. These observations contribute to a better understanding of the complex 
actions of 5-HT on PFC neuronal activity and its control of subcortical structures via descending 
inputs.  
 GABAergic neurons were identified by the presence of GAD67 mRNA. Given that both 
GAD67 and GAD65 isoforms are co-expressed in the majority of GABA-positive neurons in the 
brain (Erlander and Tobin 1991; Feldblum  et al. 1993; Esclapez  et al. 1994), we used only one 
probe to identify this neuronal type since the high level of non-radioactive signal obtained with 
two digoxygenin-labeled oligonucleotides prevented the correct visualization of silver grains 
over GAD-positive cellular profiles. 
Cortical GABAergic interneurons are classified according to several characteristics such 
as morphology, connectivity, electrophysiological properties and expression profile of 
neuropeptides and calcium binding proteins, such as parvalbumin (PV), calbindin or calretinin 
(Ascoli  et al. 2008; DeFelipe  et al. 2013). PV-positive neurons are a subpopulation of 
GABAergic cells comprising chandelier and large basket cells (DeFelipe 1997). These 
interneurons exert a tight control of the signal output from the PFC to subcortical areas since 
they synapse on cell bodies (basket cells) or in the initial segment of the axon of layer V 
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 13 
pyramidal cells (chandelier cells) (DeFelipe and Farinas 1992), where initiation of action 
potential occurs. Given that PV-positive neurons represent only a fraction of all GABA 
interneurons, the present results indicate that 5-HT2c-R are expressed by various subtypes of 
GABAergic interneurons, since the 5-HT2c-R mRNA was identified only in a small proportion of 
PV-positive GABAergic neurons. This view is also supported by the observation that 5-HT2c-R 
mRNA is also present on layer I GABAergic interneurons which are not PV-positive. Hence, 5-
HT2c-R may indirectly modulate pyramidal neuron activity by controlling axo-somatic and axo-
axonic GABAergic inputs (deep layers) as well as axo-dendritic inputs onto the tufts of apical 
dendrites (layer I). 5-HT3-R (Puig  et al. 2004) -but not 5-H11A-R or 5-HT2A-R (Santana  et al. 
2004)- are also present in layer I GABAergic interneurons, indicating the existence of a complex 
serotonergic control of distal inputs onto apical dendrites. Interestingly, inputs onto dendritic 
tufts have been considered important for associative learning and are mostly of cortical origin. 
However, 5-HT2C-R and 5-HT3-R may also modulate thalamocortical inputs, since, in addition to 
the well-known input onto layer IV, there is a dense thalamic input onto cortical layer I in all 
areas of the rodent cortex (Rubio-Garrido  et al. 2009). 
Interestingly, we found a similar proportion of pyramidal and GABAergic neurons 
expressing 5-HT2c-R mRNA in the various subdivision of the mPFC (9-16% for pyramidal 
neurons, ~10% for GABAergic interneurons). A previous immunohistochemical study reported 
the presence of 5-HT2C-R in PFC (Liu  et al. 2007). The authors found a 50% of 5-HT2C-R 
immunoreactive cells in PrL were also GAD67-positive. Although the data of the two studies are 
not directly comparable, both indicate a similar proportion of excitatory and inhibitory 
neurons expressing 5-HT2C-R in PrL. This ratio is different from 5-H11A-R and 5-HT2A-R, which 
are preferentially expressed by pyramidal neurons (Santana  et al. 2004) or from 5-HT3-R, 
which are expressed mostly by GABAergic interneurons (Morales and Bloom 1997; Puig  et al. 
2004). However, more ventral areas of the PFC, such as TT or Pir exhibited a much greater 
abundance of pyramidal neurons (>60%) expressing 5-HT2C-R, together with a larger 
pyramidal/GABAergic proportion (~3) than in dorsal PFC areas, such as mPFC. These different 
proportions indicate that 5-HT2c-R stimulation or blockade may have entirely different effects 
on pyramidal neuron activity and therefore, on the function of the different PFC subdivisions. 
Overall, the proportion of 5-HT2C-R-expressing cells in medial aspects of the PFC was 
lower than that in the piriform cortex and tenia tecta, where more than 60% of VGLUT1-
positive cells express the receptor. Likewise, the proportion of 5-HT2C-R-expressing cells in in 
medial PFC was also lower than in subcortical regions rich in 5-HT2C-R, such as the Acb, where 
more than 50% of the neurons expressed the receptor. The presence of 5-HT2C-R- in pyramidal 
and GABA neurons of the mPFC, as well as in the receptive fields of pyramidal neurons, such as 
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 14 
CPu and Acb, suggests an important –and likely complex- role of this receptor in the processing 
of information along basal ganglia circuits (see scheme in Fig. 10). Indeed, based on the 
present study, we cannot estimate the percentage of pyramidal neurons projecting to dorsal 
and ventral striatum express 5-HT2C-R mRNA. However, these pyramidal neurons are located in 
layers V-VI of Cg-PrL (CPu) and PrL-IL (Acb) subdivisions, respectively, as well as in VO/LO 
(Gabbott  et al. 2005), where cells expressing 5-HT2C-R are located. Therefore, 5-HT2C-R 
activation may directly or indirectly (via local networks) the PFC output to the striatum. 
Therefore, it is likely that endogenous 5-HT can modulate the processing of cognitive and 
affective signals along basal ganglia circuits by acting at PFC level, via the activation of 5-HT 
receptors located in deep layers (5-HT1A-R, 5-HT2A-R ad 5-HT2C-R,(Santana  et al. 2004; this 
study) as well as by activating 5-HT2C-R in striatal medium-size spiny GABA neurons receiving 
these cortical inputs. This complex interaction may also be involved in action of psychotropic 
drugs acting on 5-HT2C-R. Additionally, 5-HT2C-R in GABA cells of the midbrain raphe may exert 
a negative feed-back regulation of serotonergic activity at somatodendritic level (Serrats  et al. 
2005), which adds a further element of complexity. Hence, 5-HT2C-R blockade by atypical 
antipsychotic drugs (or of certain antidepressant drugs, such as agomelatine) may affect the 
activity of basal ganglia circuits at various levels, effects possibly involved in the therapeutic 
action of these agents.  
 
 As summarized above, 5-HT2C-R blockade has been associated with the antipsychotic-
induced weight gain. However, the presence of 5-HT2C-R in PFC suggests its involvement in the 
processing of cognitive and/or emotional signals. 5-HT2C-R blockade by antipsychotic drugs in 
PFC may add to the effects on the control of dopaminergic neurotransmission by midbrain 
5-HT2C-R (Gobert  et al. 2000; Di Matteo  et al. 2002; De Deurwaerdère  et al. 2004; Di Giovanni  
et al. 2006) since 5-HT2C-R stimulation in PFC facilitates drug-induced dopamine release in the 
nucleus accumbens (Leggio  et al. 2009). On the other hand, the selective enrichment of 5-
HT2C-R in ventral regions may indicate its participation in emotional processing, given the role 
of ventral PFC regions in emotional control. Hence, alterations of the energy metabolism in the 
ventral cingulate have been reported in mood disorders (Seminowicz  et al. 2004; Drevets  et 
al. 2008) and deep brain stimulation of these ventral areas evokes immediate antidepressant 
effects in treatment-resistant depressed patients (Mayberg  et al. 2005; Puigdemont  et al. 
2012).  
In summary, the present study shows a heterogeneous 5-HT2C-R distribution in rat PFC, 
expressed in pyramidal neurons and GABAergic interneurons in different proportions, 
depending on the area examined, although lower in most instances than that present in a 
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 15 
subcortical structure rich in 5-HT2C-R, such as Acb. The percentage of cells expressing the 
receptor exhibits marked dorso-ventral and medio-lateral (in mPFC) gradients at different AP 
coordinates. Overall, the present results improve our knowledge of the role of serotonergic 
neurotransmission in the control of PFC function and help to better understand the interaction 
of psychoactive drugs (mainly atypical antipsychotics) with PFC networks involved in cognitive 
and emotional processing. 
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Figure legends 
 
Figure 1. Expression of 5-HT2C-R mRNA at three different rostro-caudal levels of rat brain. 
Upper row: Film images of hybridized coronal sections at +2.28 mm (A1), -2.28 mm (B1) and -
5.28 mm (C1) from bregma. Lower row: atlas levels at equivalent anteroposterior coordinates 
(Paxinos and Watson 2005, with permission). Bar: 1 mm 
 
Figure 2. Rostrocaudal expression pattern of 5-HT2C-R mRNA in rat prefrontal cortex (PFC). 
Autoradiograms of PFC coronal sections of three rats (A to C) showing the density of 5-HT2C-R 
mRNA expression at five different antero-posterior levels (1: +4.2; 2: +3.7; 3: +3.2; 4: +3.0; 5: 
+2.8 mm from bregma) (Paxinos and Watson 2005). Note the higher expression of 5-HT2C-R 
mRNA in ventral areas of PFC, such as piriform cortex, taenia tecta and anterior olfactory 
nucleus, etc. 
 
Figure 3. Layer distribution of 5-HT2C-R mRNA in rat prefrontal cortex (PFC). Emulsion dipped 
PFC coronal sections hybridized with 33P-labeled 5-HT2C-R mRNA probe. Antero-posterior 
coordinates: A) +3.7 mm, B) +2.7 mm from bregma (Paxinos and Watson 2005). C) and D) are 
enlargements of A and B, respectively, showing the approximate boundaries between cortical 
layers (modified from Swanson (2004) under CC license). Note the higher expression 5-HT2C-R 
mRNA in deep (V-VI) versus superficial and intermediate (I-III) layers of medial PFC. Ventral 
areas, such as anterior olfactory nucleus, tenia tecta and piriform cortex, as well as nucleus 
accumbens, show a great abundance of this receptor. AON, anterior olfactory nucleus; Cg, 
anterior cingulate cortex; AI, agranular insular area; IL, infralimbic cortex; M1/M2, 
primary/secondary motor cortex; Acb, nucleus accumbens; VO/LO, ventral/lateral orbital 
cortex; Pir, piriform cortex ; PrL, prelimbic cortex; TT, taenia tecta. I to VI numbering denotes 
cortical layers. Bar: 1mm 
 
Figure 4. High magnification photomicrographs showing the co-localization of 5-HT2C-R mRNA 
with glutamatergic (VGLUT1-positive) (A), GABAergic (GAD-positive) (B) and parvalbumin-
positive (C) cells in layers II-III (left column) and V-VI (right column) of the prelimbic cortex. 
Receptor probes are radioactively labeled (seen as silver grain precipitates) and neuronal 
marker probes are labeled with digoxigenin (seen as a dark stain precipitate). White 
arrowheads mark cells positive for 5-HT2C receptor mRNA. Double labeled cells are marked by 
black arrowheads. For simplicity, only few cells of each type are marked. Higher magnification 
Page 23 of 38 Cerebral Cortex
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
 24 
images of selected double-labeled cells are shown as insets on top-right corner of each panel. 
A greater number of glutamatergic cells in layers V-VI vs layers II-III expressed the 5-HT2C 
receptor mRNA, as denoted by the double labeling (A1,A2). Some GABAergic (B) and PV-
positive (C) cells also expressed this receptor. Large bar: 50µm, small bar: 10 µm. 
 
Figure 5. 5-HT2C receptor in ventral areas of PFC. Co-localization of 5-HT2C-R mRNA (
33P-labeled 
oligonucleotides, seen as silver grains) with glutamatergic (VGLUT1-positive, column A), 
GABAergic (GAD-positive, column B) and PV-positive (column C) cells in nucleus accumbens 
(A1-C1), agranular insular cortex (A2-C2), orbital cortex (A3-C3), piriform cortex (A4-C4) and 
anterior olfactory nucleus (A5-C5). Note the great abundance of 5-HT2C-R mRNA in the two 
latter structures, as well as in nucleus accumbens. White arrowheads mark cells positive for 5-
HT2C receptor mRNA. Double labeled cells are marked by black arrowheads. For simplicity, only 
few cells of each type are marked. Bar: 20 µm 
 
Figure 6. Bar graph showing the expression of 5-HT2C-R mRNA in PFC subdivisions. Data (mean 
± SEM) are percentages of total pyramidal (VGLUT1-positive), GABAergic (GAD-positive) or PV-
containing neurons expressing 5-HT2C-R mRNA. *p<0.05 vs Cg, Tukey test post-ANOVA. Layer I 
denotes the superficial layer of medial PFC; Cg, anterior cingulate cortex, dorsal part; PrL, 
prelimbic cortex; IL, infralimbic cortex; VO/LO, ventral/lateral orbital cortex; AI, agranular 
insular cortex; TT, tenia tecta; Pir, piriform cortex.  
 
Figure 7. Bar graphs showing the layer distribution of 5-HT2C-R mRNA in mPFC. Bars show the 
percentage of total pyramidal (VGLUT1-positive), GABAergic (GAD-positive) or parvalbumin 
(PV)-positive neurons expressing 5-HT2C receptor mRNA in layers II-III (grey bars) and V-VI 
(black bars) of the infralimbic (IL), prelimbic (PrL) and cingulate (Cg) subdivisions of medial PFC. 
Data are mean ± SEM of three rats per group. *P<0.05 vs layer II-III, two-way ANOVA followed 
by Bonferroni post-hoc test. 
 
Figure 8. Expression of 5-HT2C-R mRNA in rostral PFC. A) Emulsion dipped coronal section at 
anteroposterior (AP) coordinate +5.1 mm from bregma (Paxinos and Watson 2005) hybridized 
with 33P-labeled 5-HT2C-R mRNA probe. M1/M2, primary/secondary motor cortex; Fr3, frontal 
cortex, area 3; PrL, prelimbic cortex; MO, medial orbital cortex; VO/LO, ventra/lateral orbital 
cortex; DLO, dorsolateral orbital cortex. I to VI numbering denotes cortical layers. Bar: 1 mm. 
B1) Bar graphs showing the expression of 5-HT2C-R mRNA in rostral PFC subdivisions. Data 
(mean ± SEM) are percentages of total pyramidal (VGLUT1-positive) and GABAergic (GAD-
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positive) neurons expressing 5-HT2C-R mRNA. n.s, one-way ANOVA. B2,B3) Bar graphs showing 
the layer distribution of 5-HT2C-R mRNA in VO/LO and DLO cortices. Bars show the percentage 
of total pyramidal (VGLUT1-positive) or GABAergic (GAD-positive) neurons expressing 5-HT2C 
receptor mRNA in layers II-III (grey bars) and V-VI (black bars) of the ventrolateral (VO/LO) and 
dorsolateral (DLO) subdivisions of orbital cortex. Data are mean ± SEM of three rats per group. 
*p<0.05 vs layer II-III, two-way ANOVA followed by Bonferroni post-hoc test. C) High 
magnification photomicrographs showing the co-localization of 5-HT2C-R mRNA with 
glutamatergic (VGLUT1-positive) cells in VO/LO (C1) or DLO (C2) and with GABAergic (GAD-
positive) neurons in these same areas (C3,C4, respectively). Receptor probes are radioactively 
labeled (seen as silver grain precipitates) and cell marker probes are labeled with digoxigenin 
(seen as a dark stain precipitate). Double labeled cells are marked by black arrowheads. For 
simplicity, only few cells of each type are marked. Higher magnification images of selected 
double-labeled cells are shown as insets on top-right corner of each panel. Large bar: 50 µm, 
small bar: 10 µm. 
 
Figure 9. Expression of 5-HT2C-R mRNA in striatum. A) Emulsion dipped coronal section at AP 
+2.2 mm from bregma (Paxinos and Watson 2005) hybridized with 33P-labeled 5-HT2C-R mRNA 
probe. Dashed lines show the approximate boundaries between striatum subdivisions (Paxinos 
and Watson 2005, Voorn  et al. 2004). B) High magnification photomicrographs showing the 
co-localization of 5-HT2C-R mRNA with glutamatergic GABAergic (GAD-positive) cells in dlCPu 
(B1), vmCPu (B2), Acb Core (B3) and Acb Shell (B4). Receptor probes are radioactively labeled 
(seen as silver grain precipitates) and GAD probes are labeled with digoxigenin (seen as a dark 
stain precipitate). Double labeled cells are marked by black arrowheads. For simplicity, only 
few cells of each type are marked. Higher magnification images of selected double-labeled 
cells are shown as insets on top-right corner of each panel. Large bar: 50 µm, small bar: 10 µm. 
C) Bar graph showing the expression of 5-HT2C-R mRNA in striatum subdivisions. Data (mean ± 
SEM) are percentages of total GABAergic (GAD-positive) neurons expressing 5-HT2C-R mRNA. 
*p<0.05 vs dlCPu, #p<0.05 vs vmCPu, Tukey test post-ANOVA. dlCPu, dorsolateral caudate-
putamen; vmCPu, ventromedial caudate-putamen; AcbC, nucleus accumbens, core; AcbSh, 
nucleus accumbens, shell.  
 
Figure 10. Schematic representation of the expression of 5-HT2C-R. In PFC, in basal ganglia 
circuits. Deep layers of the mPFC contain the pyramidal neurons projecting to midbrain (e.g., 
dorsal and median raphe nuclei, DR/MnR and ventral tegmental area, VTA, (not shown in the 
figure)) and to dorsal and ventral striatum (CPu, caudate-putamen and Acb, nucleus 
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accumbens, respectively). 5-HT2c-R are also expressed in a high proportion of medium-size 
spiny GABA neurons in the striatum, as well as in substantia nigra reticulata (SNr) (Eberle-
Wang  et al. 1997), which receives striatal inputs through the direct and indirect pathways (the 
latter via globus pallidus, ventral pallidum and subthalamic nucleus, GP, VP and STN, 
respectively). GABA cells in the SNr tonically inhibit excitatory neurons in thalamic nuclei. 
Several thalamic nuclei (but not the mediodorsal and centromedial nuclei -MD/CM- that 
project to PFC) contain a high density of cells expressing 5-HT2c-R, (Clemett  et al. 2000). 
Thalamic inputs reach the neocortex in layers I and IV (Rubio-Garrido  et al. 2007), except in 
PFC, lacking layer IV, where thalamic inputs input reach layers III, V and VI (Kuroda  et al. 
1998). In addition, most GABA neurons in the dorsal raphe nucleus (DR) express 5-HT2C-R 
(Serrats  et al. 2005), which may exert a local negative feed-back mechanism on 5-HT neuronal 
activity.  
 
Figure 11.  Comparison of monoaminergic receptors mRNA expression in rat prefrontal cortex 
(PFC). A) Emulsion dipped PFC coronal sections hybridized with 33P-labeled 5-HT2C-R mRNA 
probe. Antero-posterior coordinate: +3.7 mm from bregma (Paxinos and Watson 2005). A1 to 
A9 correspond to each of the nine receptors analized (see bar graph titles). B) Bar graphs 
showing the expression of 5-HT2C-R mRNA in medial PFC subdivisions of the same receptors.  
Data (mean ± SEM of three rats, two/three consecutive sections per rat) are percentages of 
total pyramidal (VGLUT1-positive) or GABAergic (GAD-positive) neurons expressing 5-HT2C-R 
mRNA. Cg, anterior cingulate cortex; PrL, prelimbic cortex; IL, infralimbic cortex. Bar: 1mm 
 
Page 26 of 38Cerebral Cortex
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
  
 
 
Figure 1. Expression of 5-HT2C-R mRNA at three different rostro-caudal levels of rat brain. Upper row: Film 
images of hybridized coronal sections at +2.28 mm (A1), -2.28 mm (B1) and -5.28 mm (C1) from bregma. 
Lower row: atlas levels at equivalent anteroposterior coordinates (Paxinos and Watson 2005, with 
permission). Bar: 1 mm  
92x47mm (300 x 300 DPI)  
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Figure 2. Rostrocaudal expression pattern of 5-HT2C-R mRNA in rat prefrontal cortex (PFC). Autoradiograms 
of PFC coronal sections of three rats (A to C) showing the density of 5-HT2C-R mRNA expression at five 
different antero-posterior levels (1: +4.2; 2: +3.7; 3: +3.2; 4: +3.0; 5: +2.8 mm from bregma) (Paxinos 
and Watson 2005). Note the higher expression of 5-HT2C-R mRNA in ventral areas of PFC, such as piriform 
cortex, taenia tecta and anterior olfactory nucleus, etc.  
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Figure 3. Layer distribution of 5-HT2C-R mRNA in rat prefrontal cortex (PFC). Emulsion dipped PFC coronal 
sections hybridized with 33P-labeled 5-HT2C-R mRNA probe. Antero-posterior coordinates: A) +3.7 mm, B) 
+2.7 mm from bregma (Paxinos and Watson 2005). C) and D) are enlargements of A and B, respectively, 
showing the approximate boundaries between cortical layers (modified from Swanson (2004) under CC 
license). Note the higher expression 5-HT2C-R mRNA in deep (V-VI) versus superficial and intermediate (I-
III) layers of medial PFC. Ventral areas, such as anterior olfactory nucleus, tenia tecta and piriform cortex, 
as well as nucleus accumbens, show a great abundance of this receptor. AON, anterior olfactory nucleus; 
Cg, anterior cingulate cortex; AI, agranular insular area; IL, infralimbic cortex; M1/M2, primary/secondary 
motor cortex; Acb, nucleus accumbens; VO/LO, ventral/lateral orbital cortex; Pir, piriform cortex ; PrL, 
prelimbic cortex; TT, taenia tecta. I to VI numbering denotes cortical layers. Bar: 1mm  
244x331mm (300 x 300 DPI)  
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Figure 4. High magnification photomicrographs showing the co-localization of 5-HT2C-R mRNA with 
glutamatergic (VGLUT1-positive) (A), GABAergic (GAD-positive) (B) and parvalbumin-positive (C) cells in 
layers II-III (left column) and V-VI (right column) of the prelimbic cortex. Receptor probes are radioactively 
labeled (seen as silver grain precipitates) and neuronal marker probes are labeled with digoxigenin (seen as 
a dark stain precipitate). White arrowheads mark cells positive for 5-HT2C receptor mRNA. Double labeled 
cells are marked by black arrowheads. For simplicity, only few cells of each type are marked. Higher 
magnification images of selected double-labeled cells are shown as insets on top-right corner of each panel. 
A greater number of glutamatergic cells in layers V-VI vs layers II-III expressed the 5-HT2C receptor mRNA, 
as denoted by the double labeling (A1, A2). Some GABAergic (B) and PV-positive (C) cells also expressed 
this receptor. Large bar: 50µm, small bar: 10 µm.  
180x215mm (300 x 300 DPI)  
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Figure 5. 5-HT2C-R in ventral areas of PFC. Co-localization of 5-HT2C-R mRNA (33P-labeled 
oligonucleotides, seen as silver grains) with glutamatergic (VGLUT1-positive, column A), GABAergic (GAD-
positive, column B) and PV-positive (column C) cells in nucleus accumbens (A1-C1), agranular insular cortex 
(A2-C2), orbital cortex (A3-C3), piriform cortex (A4-C4) and anterior olfactory nucleus (A5-C5). Note the 
great abundance of 5-HT2C-R mRNA in the two latter structures, as well as in nucleus accumbens. White 
arrowheads mark cells positive for 5-HT2C-R mRNA. Double labeled cells are marked by black arrowheads. 
For simplicity, only few cells of each type are marked. Bar: 20 µm  
229x291mm (300 x 300 DPI)  
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Figure 6. Bar graph showing the expression of 5-HT2C-R mRNA in PFC subdivisions. Data (mean ± SEM) are 
percentages of total pyramidal (VGLUT1-positive), GABAergic (GAD-positive) or PV-containing neurons 
expressing 5-HT2C-R mRNA. *p<0.05 vs Cg, Tukey test post-ANOVA. Layer I denotes the superficial layer of 
medial PFC; Cg, anterior cingulate cortex, dorsal part; PrL, prelimbic cortex; IL, infralimbic cortex; VO/LO, 
ventral/lateral orbital cortex; AI, agranular insular cortex; TT, tenia tecta; Pir, piriform cortex.  
60x42mm (600 x 600 DPI)  
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Figure 7. Bar graphs showing the layer distribution of 5-HT2C-R mRNA in mPFC. Bars show the percentage 
of total pyramidal (VGLUT1-positive), GABAergic (GAD-positive) or parvalbumin (PV)-positive neurons 
expressing 5-HT2C-R mRNA in layers II-III (grey bars) and V-VI (black bars) of the infralimbic (IL), 
prelimbic (PrL) and cingulate (Cg) subdivisions of medial PFC. Data are mean ± SEM of three rats per group. 
*P<0.05 vs layer II-III, two-way ANOVA followed by Bonferroni post-hoc test.  
23x6mm (600 x 600 DPI)  
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Figure 8. Expression of 5-HT2C-R mRNA in rostral PFC. A) Emulsion dipped coronal section at 
anteroposterior (AP) coordinate +5.1 mm from bregma (Paxinos and Watson 2005) hybridized with 33P-
labeled 5-HT2C-R mRNA probe. M1/M2, primary/secondary motor cortex; Fr3, frontal cortex, area 3; PrL, 
prelimbic cortex; MO, medial orbital cortex; VO/LO, ventra/lateral orbital cortex; DLO, dorsolateral orbital 
cortex. I to VI numbering denotes cortical layers. Bar: 1 mm. B1) Bar graphs showing the expression of 5-
HT2C-R mRNA in rostral PFC subdivisions. Data (mean ± SEM) are percentages of total pyramidal (VGLUT1-
positive) and GABAergic (GAD-positive) neurons expressing 5-HT2C-R mRNA. n.s, one-way ANOVA. B2,B3) 
Bar graphs showing the layer distribution of 5-HT2C-R mRNA in VO/LO and DLO cortices. Bars show the 
percentage of total pyramidal (VGLUT1-positive) or GABAergic (GAD-positive) neurons expressing 5-HT2C 
receptor mRNA in layers II-III (grey bars) and V-VI (black bars) of the ventrolateral (VO/LO) and 
dorsolateral (DLO) subdivisions of orbital cortex. Data are mean ± SEM of three rats per group. *p<0.05 vs 
layer II-III, two-way ANOVA followed by Bonferroni post-hoc test. C) High magnification photomicrographs 
showing the co-localization of 5-HT2C-R mRNA with glutamatergic (VGLUT1-positive) cells in VO/LO (C1) or 
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DLO (C2) and with GABAergic (GAD-positive) neurons in these same areas (C3,C4, respectively). Receptor 
probes are radioactively labeled (seen as silver grain precipitates) and cell marker probes are labeled with 
digoxigenin (seen as a dark stain precipitate). Double labeled cells are marked by black arrowheads. For 
simplicity, only few cells of each type are marked. Higher magnification images of selected double-labeled 
cells are shown as insets on top-right corner of each panel. Large bar: 50 µm, small bar: 10 µm.  
219x268mm (300 x 300 DPI)  
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Figure 9. Expression of 5-HT2C-R mRNA in striatum. A) Emulsion dipped coronal section at AP +2.2 mm 
from bregma (Paxinos and Watson 2005) hybridized with 33P-labeled 5-HT2C-R mRNA probe. Dashed lines 
show the approximate boundaries between striatum subdivisions (Paxinos and Watson 2005, Voorn et al. 
2004). B) High magnification photomicrographs showing the co-localization of 5-HT2C-R mRNA with 
glutamatergic GABAergic (GAD-positive) cells in dlCPu (B1), vmCPu (B2), Acb Core (B3) and Acb Shell (B4). 
Receptor probes are radioactively labeled (seen as silver grain precipitates) and GAD probes are labeled with 
digoxigenin (seen as a dark stain precipitate). Double labeled cells are marked by black arrowheads. For 
simplicity, only few cells of each type are marked. Higher magnification images of selected double-labeled 
cells are shown as insets on top-right corner of each panel. Large bar: 50 µm, small bar: 10 µm. C) Bar 
graph showing the expression of 5-HT2C-R mRNA in striatum subdivisions. Data (mean ± SEM) are 
percentages of total GABAergic (GAD-positive) neurons expressing 5-HT2C-R mRNA. *p<0.05 vs dlCPu, 
#p<0.05 vs vmCPu, Tukey test post-ANOVA. dlCPu, dorsolateral caudate-putamen; vmCPu, ventromedial 
caudate-putamen; AcbC, nucleus accumbens, core; AcbSh, nucleus accumbens, shell.  
908x471mm (150 x 150 DPI)  
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Figure 10. Schematic representation of the expression of 5-HT2C-R. In PFC, in basal ganglia circuits. Deep 
layers of the mPFC contain the pyramidal neurons projecting to midbrain (e.g., dorsal and median raphe 
nuclei, DR/MnR and ventral tegmental area, VTA, (not shown in the figure)) and to dorsal and ventral 
striatum (CPu, caudate-putamen and Acb, nucleus accumbens, respectively). 5-HT2c-R are also expressed 
in a high proportion of medium-size spiny GABA neurons in the striatum, as well as in substantia nigra 
reticulata (SNr) (Eberle-Wang 1997), which receives striatal inputs through the direct and indirect pathways 
(the latter via globus pallidus, ventral pallidum and subthalamic nucleus, GP, VP and STN, respectively). 
GABA cells in the SNr tonically inhibit excitatory neurons in thalamic nuclei. Several thalamic nuclei (but not 
the mediodorsal and centromedial nuclei -MD/CM- that project to PFC) contain a high density of cells 
expressing 5-HT2c-R, (Clemett 2000). Thalamic inputs reach the neocortex in layers I and IV (Rubio-Garrido 
2007), except in PFC, lacking layer IV, where thalamic inputs input reach layers III, V and VI (Kuboda 
1998). In addition, most GABA neurons in the dorsal raphe nucleus (DR) express 5-HT2C-R (Serrats 2005), 
which may exert a local negative feed-back mechanism on 5-HT neuronal activity.  
54x34mm (600 x 600 DPI)  
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Figure 11.  Comparison of monoaminergic receptors mRNA expression in rat prefrontal cortex (PFC). A) 
Emulsion dipped PFC coronal sections hybridized with 33P-labeled 5-HT2C-R mRNA probe. Antero-posterior 
coordinate: +3.7 mm from bregma (Paxinos and Watson 2005). A1 to A9 correspond to each of the nine 
receptors analized (see bar graph titles). B) Bar graphs showing the expression of 5-HT2C-R mRNA in 
medial PFC subdivisions of the same receptors.  Data (mean ± SEM of three rats, two/three consecutive 
sections per rat) are percentages of total pyramidal (VGLUT1-positive) or GABAergic (GAD-positive) neurons 
expressing 5-HT2C-R mRNA. Cg, anterior cingulate cortex; PrL, prelimbic cortex; IL, infralimbic cortex. Bar: 
1mm  
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SUPPLEMENTARY TABLE 
 
Table 1. Expression of 5-HT2C receptor mRNA in pyramidal (VGLUT1-positive), GABAergic (GAD-
positive) and parvalbumin (PV)-containing cells in several areas of rat prefrontal cortex. Data 
(mean ± SEM) are percentages of total pyramidal, GABAergic or PV neurons expressing 5-HT2C 
mRNA. *p < 0.05 vs Cg,  Tukey test post-ANOVA. Layer I denotes the superficial layer of medial 
PFC; Cg, anterior cingulate cortex; PrL, prelimbic cortex; IL, infralimbic cortex; VO/LO, 
ventral/lateral orbital cortex; AI, agranular insular cortex; TT, tenia tecta; Pir, piriform cortex.  
 
 vGluT1 GAD PV 
Layer I (mPFC) -- 10 ± 3 -- 
Cg 10 ± 1 14 ± 1 4 ± 2 
PrL 14 ± 1 15 ± 2 7 ± 2 
IL 16 ± 2* 19 ± 3 7 ± 4 
VO/LO 7 ± 0 3 ± 1* 1 ± 0 
AI 19 ± 1* 8 ± 2 8 ± 0 
TT 62 ± 1* 28 ± 2* 15 ± 8 
Pir 66 ± 1* 17 ± 1 10 ± 1 
  
 
Page 39 of 38 Cerebral Cortex
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
